Deep Pharma Intelligence (DPI) is a leading strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, BioTech, and Healthcare Tech industries.
The company is a joint venture between the two highly specialized UK-based market intelligence hubs in Pharma / BioTech space:
Pharma Division of Deep Knowledge Analytics (PD-DKA), a specialized subsidiary of Deep Knowledge Analytics (DKA), the leading analytical entity specifically focused on deep intelligence of the high-potential areas in the pharma industry, including artificial intelligence (AI) for drug discovery sector.
Deep Knowledge Analytics Pharma Division serves as the main source of investment intelligence and analytics for AI-Pharma, a specialized index hedge fund for the AI in the drug discovery sector. PD-DKA’s insights are frequently covered by top media such as Forbes and the Financial Times, and are acknowledged by top pharma executives.
Recently, MIT named this division a top technology think-tank, acknowledging the AI ranking framework it developed.
BPT Analytics (BiopharmaTrend) - a rapidly growing analytical portal and media resource, dedicated to tracking emerging companies (startups/scaleups), innovations, investments, and trends in the pharma and biotech space.
BiopharmaTrend’s reports and articles were referenced by Deloitte, Forbes, and other high profile media and consulting companies.
BiopharmaTrend is a media partner to a number of top-tier conferences and symposia in preclinical and clinical research, and healthcare research.
Our range of proprietary services includes custom consulting projects, based on the specific customer needs, as well as a collection of pre-produced “ready-to-use” proprietary reports, produced by our research team, covering general trends and specific action ideas and strategy insights related to the most promising investment prospects (e.g. new technologies, BioTech startups), M&A prospects (e.g. pipeline development targets), and strategic growth ideas (trends profiling, industry overviews etc).
The Yuan is a new tech community platform focused on AI in healthcare, ML, and related disciplines. Their aim is to provide an open forum for global innovators, entrepreneurs, and others in the AI world to exchange insights into this transformational technology. The company is seeking talented AI professionals and social commentators to share their expertise and wisdom to inform our readership of investors, scientists, researchers, engineers, graduate students, policymakers, healthcare providers and patients, and the public at large, of developments in this novel arena that is poised to become central to every of a field of human endeavor.
SHANDA CONSULT is an international consulting firm based in Nicosia, Cyprus, with a wide network of trusted partners in the European Union, the Mediterranean, the Middle East, and Asia. The company offers an integrated range of business advisory services designed to facilitate and initiate cross-border industrial investments. They support clients with corporate restructuring and performance improvement and facilitate corporate relocation and business localization, including establishing a new representative and branch offices and special purpose vehicles for investments and market entry.
SPAC Consultants is an A to Z one-stop solution specialized in structuring and setting up Special-Purpose Acquisition Companies. Together with its international team and associates, being among the heavyweights of the SPAC Space, SPAC Consultants professionally advises on and structures SPACs, taking them to successful IPO, mainly at NASDAQ and NYSE.